Engineers Gate Manager
JSPR icon

Engineers Gate Manager’s Jasper Therapeutics JSPR Stock Holding History

Engineers Gate Manager’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.47K Sell
12,989
-13,142
-50% -$9.84K ﹤0.01% 2192
2026
Q1 		$22.9K Buy
26,131
+11,874
+83% +$16.5K ﹤0.01% 2117
2025
Q4 		$26.1K Buy
+14,257
New +$28.6K ﹤0.01% 2019
2025
Q3 		– Sell
-13,972
Closed -$77.5K – 2354
2025
Q2 		$77.5K Buy
+13,972
New +$68.8K ﹤0.01% 2026

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Engineers Gate Manager's JSPR Position: Q2 2026 in Review

Engineers Gate Manager reduced its Jasper Therapeutics (JSPR) stake by 50% in Q2 2026, selling an estimated $9.84K and leaving 12,989 shares worth $5.47K. The position accounts for ﹤0.01% of the portfolio, ranked #2192.

Engineers Gate Manager first reported a position in JSPR in Q2 2025 and has held it in 4 quarters since. The position peaked at $77.5K in Q2 2025. 45 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

  • Engineers Gate Manager held 12,989 shares of Jasper Therapeutics worth $5.47K as of Q2 2026.
  • Engineers Gate Manager sold 13,142 Jasper Therapeutics shares in Q2 2026, an estimated $9.84K.
  • Jasper Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2192 holding.
  • Engineers Gate Manager first reported a position in Jasper Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Engineers Gate Manager's Jasper Therapeutics position peaked at $77.5K in Q2 2025.
  • 45 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.